Skip to main content
. 2022 May;23(5):682–690. doi: 10.1016/S1470-2045(22)00145-0

Table 4.

Treatment timelines

Median (IQR), days Patients assessed, n
Time from completion of neoadjuvant chemotherapy to preoperative radiotherapy 30·0 (30·0) 30
Time from preoperative radiotherapy to mastectomy 20·0 (11·0) 33
Time from completion of neoadjuvant chemotherapy to mastectomy 69·0 (32·0) 30
Time from diagnosis to mastectomy 230·0 (76·0) 33

Treatment dates and timelines were available for all patients; since three patients did not receive neoadjuvant chemotherapy, these patients have been excluded from computations of time from completion of neoadjuvant chemotherapy to preoperative radiotherapy and time from completion of neoadjuvant chemotherapy to mastectomy.